We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
+$660M
Cap. Flow
+$542M
Cap. Flow %
18.28%
Top 10 Hldgs %
31.64%
Holding
3,611
New
266
Increased
1,484
Reduced
936
Closed
189
Avg Time Held Equity + Options
3.4 years
Top 10 Avg Time Held Equity + Options
2 years
Top 20 Avg Time Held Equity + Options
2.3 years
Avg Time Held Equity only
3.5 years
Top 10 Avg Time Held Equity only
2 years
Top 20 Avg Time Held Equity only
2.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.73%
2 Technology 13.87%
3 Healthcare 8.82%
4 Financials 7.01%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
OSW icon
3201
OneSpaWorld
OSW
$2.43B
$360 ﹤0.01%
+30
New +$327
2023 Q1
0 quarters
HT
3202
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$360 ﹤0.01%
53
+13
+33% +$105
2017 Q1
24 quarters
CBAY icon
3203
DELISTED
Cymabay Therapeutics
CBAY
$358 ﹤0.01%
+41
New +$328
2023 Q1
0 quarters
TEAF
3204
DELISTED
Ecofin Sustainable & Social Impact Term Fund
TEAF
$357 ﹤0.01%
27
+1
+4% +$13
2021 Q4
5 quarters
VRRM icon
3205
Verra Mobility
VRRM
$447M
$355 ﹤0.01%
21
-16
-43% -$256
2021 Q3
6 quarters
RVNC icon
3206
DELISTED
Revance Therapeutics, Inc.
RVNC
$354 ﹤0.01%
+11
New +$343
2023 Q1
0 quarters
HIBB icon
3207
DELISTED
Hibbett, Inc. Common Stock
HIBB
$354 ﹤0.01%
6
– –
2021 Q1
8 quarters
GKOS icon
3208
Glaukos
GKOS
$9.77B
$351 ﹤0.01%
7
– –
2021 Q4
5 quarters
MLAB icon
3209
Mesa Laboratories
MLAB
$715M
$349 ﹤0.01%
2
– –
2022 Q4
1 quarter
IMCR icon
3210
Immunocore
IMCR
$1.52B
$346 ﹤0.01%
7
-31
-82% -$1.74K
2022 Q3
2 quarters
PLUS icon
3211
ePlus
PLUS
$2.48B
$343 ﹤0.01%
7
– –
2020 Q4
9 quarters
OCFC icon
3212
OceanFirst Financial
OCFC
$1.54B
$333 ﹤0.01%
18
– –
2022 Q2
3 quarters
INDB icon
3213
Independent Bank
INDB
$3.65B
$328 ﹤0.01%
5
-27
-84% -$2.06K
2021 Q4
5 quarters
ARLO icon
3214
Arlo Technologies
ARLO
$1.34B
$327 ﹤0.01%
54
– –
2022 Q4
1 quarter
FG icon
3215
F&G Annuities & Life
FG
$2.57B
$326 ﹤0.01%
18
-45
-71% -$901
2022 Q4
1 quarter
SAH icon
3216
Sonic Automotive
SAH
$2.01B
$326 ﹤0.01%
6
– –
2022 Q3
2 quarters
MRSN icon
3217
DELISTED
Mersana Therapeutics
MRSN
$321 ﹤0.01%
3
– –
2022 Q2
3 quarters
CVCO icon
3218
Cavco Industries
CVCO
$4.12B
$318 ﹤0.01%
1
– –
2022 Q3
2 quarters
GERN icon
3219
Geron
GERN
$790M
$317 ﹤0.01%
146
– –
2022 Q2
3 quarters
DLY icon
3220
DoubleLine Yield Opportunities Fund
DLY
$636M
$315 ﹤0.01%
22
+1
+5% +$14
2021 Q4
5 quarters
SLP icon
3221
DELISTED
Simulations Plus
SLP
$308 ﹤0.01%
7
– –
2021 Q1
8 quarters
BZ icon
3222
Kanzhun
BZ
$7.17B
$304 ﹤0.01%
+16
New +$349
2023 Q1
0 quarters
IPI icon
3223
Intrepid Potash
IPI
$434M
$304 ﹤0.01%
11
-34
-76% -$1.03K
2022 Q2
3 quarters
LSPD icon
3224
Lightspeed Commerce
LSPD
$1.41B
$304 ﹤0.01%
+20
New +$317
2023 Q1
0 quarters
FLNG icon
3225
FLEX LNG
FLNG
$1.55B
$302 ﹤0.01%
9
– –
2022 Q2
3 quarters

Similar funds

Parallel Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Parallel Advisors held 3,611 positions worth $2.97B, up 29% from $2.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parallel Advisors deployed $542M of net new capital in Q1 2023, opening 266 new positions and adding to 1,484 existing holdings. Its largest new stake was Vanguard International Dividend Appreciation ETF: 74,827 shares worth $5.51M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 54% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street Energy Select Sector SPDR ETF, an estimated $21.8M trimmed.

  • Parallel Advisors's largest Q1 2023 buy was Vanguard International Dividend Appreciation ETF: 74,827 shares worth $5.51M.
  • Parallel Advisors added most to iShares 0-1 Year Treasury Bond ETF in Q1 2023, an estimated $38.1M increase.
  • Parallel Advisors's biggest Q1 2023 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $21.8M.
  • Parallel Advisors fully exited 1Life Healthcare in Q1 2023, selling an estimated $1.96M.
  • Parallel Advisors's ten largest holdings make up 32% of its $2.97B portfolio in Q1 2023.
  • Parallel Advisors opened 266 new positions and closed 189 in Q1 2023.
  • Parallel Advisors's portfolio value rose 29% quarter-over-quarter to $2.97B.

Based on Parallel Advisors's 13F filing for Q1 2023, filed 25 Apr 2023.